Datar Cancer Genetics Limited
Praveen Bharamagoudar currently serves as Chief Business Officer for India and Southeast Asia at Datar Cancer Genetics Limited since April 2025. Prior to this role, Praveen held various leadership positions at MEDGENOME from January 2018 to March 2025, including Vice President of Oncology Sales and CDx, Director of Sales, and Associate Director of Oncology Marketing. Between April 2016 and January 2018, Praveen was Director of Business Development and Marketing at OncoStem Diagnostics Pvt Ltd. Previous experience includes a tenure at OncoQuest Laboratories Ltd as General Manager of Clinical Trials, along with various roles in business development and sales from March 2004 to March 2016 at different divisions of OncQuest and Dabur Pharma. Praveen holds an M.B.A. in Marketing and Operations from Karnataka State Open University and a Diploma in Pharmacy from Vishveshwara Institute Of Pharmaceutical Science.
This person is not in any teams
This person is not in any offices
Datar Cancer Genetics Limited
We are a World-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting. The facility is NABL, ISO, CAP and CLIA accredited. National and international cancer research institutes, and patients from all over the world including US, Switzerland, Germany and UK avail our services. With the help of latest technology and several years of extensive research, we offer highly effective treatment solutions to cancer patients for whom, multiple lines of treatment have failed. Our state-of-the-art cancer research centre is spread over 40,000 sq.ft. with a formidable team of cancer researchers, doctors, scientists and other technologists educated and trained at top universities and institutes around the world. Our entire team is always at the disposal of clinicians and cancer patients to bring cutting-edge treatment options in the most challenging cases.